White L R, Edvinsson L, Aasly J
Nevrologisk avdeling, Regionsykehuset i Trondheim.
Tidsskr Nor Laegeforen. 1994 Sep 30;114(23):2719-21.
This article reviews recent developments in the field of vasoactive peptides in relation to certain types of headache. The equilibrium existing in the brain between contraction and dilatation of blood vessels is controlled by, among other factors, vasoactive peptides. Several of these have been discovered only recently and constitute a rapidly expanding field of research with exciting perspectives. Cranial blood vessels are innervated by sympathetic, parasympathetic and sensory nerve fibres, all of which contain certain vasoactive peptides as co-transmitters. Others, like endothelin, can be produced by the endothelium. There is evidence to suggest that vasoactive peptides of the trigeminovascular system are liberated in response to abnormal constriction of cranial blood vessels and contribute to headache. New drug therapies based on the activity of such substances are now being developed.
本文综述了血管活性肽领域与某些类型头痛相关的最新进展。除其他因素外,血管活性肽控制着大脑中血管收缩与扩张之间的平衡。其中一些血管活性肽是最近才发现的,构成了一个迅速发展且前景令人兴奋的研究领域。颅脑血管由交感神经、副交感神经和感觉神经纤维支配,所有这些神经纤维都含有某些血管活性肽作为共递质。其他一些,如内皮素,可由内皮产生。有证据表明,三叉神经血管系统的血管活性肽会因颅脑血管异常收缩而释放,并导致头痛。基于这类物质活性的新药疗法正在研发中。